Restoring mitophagy in prostate cancer cells: the role of miR-141 rescue in counteracting MAPK1/ERK2-dependent autophagy suppression

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):1–16. doi: 10.3322/caac.21660.
   Web of Science ®Google Scholar
• Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68(6):1777–1785. doi: 10.1158/0008-5472.CAN-07-5259.
   PubMed Web of Science ®Google Scholar
• Hayrabedyan S, Todorova K, Zasheva D, et al. Haberlea rhodopensis has potential as a new drug source based on its broad biological modalities. Biotechnol Biotechnol Equip. 2013;27(1):3553–3560.
   Web of Science ®Google Scholar
• Zhou YY, Li Y, Jiang WQ, et al. MAPK/JNK signalling: a potential autophagy regulation pathway. Biosci Rep. 2015;35(3):e00199.
   PubMedGoogle Scholar
• Vara-Perez M, Felipe-Abrio B, Agostinis P. Mitophagy in cancer: a tale of adaptation. Cells. 2019;8(5):493. doi: 10.3390/cells8050493.
   PubMed Web of Science ®Google Scholar
• Durcan TM, Fon EA. The three ‘P’s of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev. 2015;29(10):989–999. doi: 10.1101/gad.262758.115.
   PubMed Web of Science ®Google Scholar
• Iorio R, Celenza G, Petricca S. Mitophagy: molecular mechanisms, new concepts on Parkin activation and the emerging role of AMPK/ULK1 axis. Cells. 2021;11(1):30. doi: 10.3390/cells11010030.
   PubMed Web of Science ®Google Scholar
• Belousov DM, Mikhaylenko EV, Somasundaram SG, et al. The dawn of mitophagy: what do we know by now? Curr Neuropharmacol. 2021;19(2):170–192. doi: 10.2174/1570159X18666200522202319.
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol. 2009;335:1–32. doi: 10.1007/978-3-642-00302-8_1.
   PubMed Web of Science ®Google Scholar
• Deas E, Wood NW, Plun-Favreau H. Mitophagy and Parkinson’s disease: the PINK1–Parkin link. Biochim Biophys Acta. 2011;1813(4):623–633. doi: 10.1016/j.bbamcr.2010.08.007.
   PubMed Web of Science ®Google Scholar
• Farrow JM, Yang JC, Evans CP. Autophagy as a modulator and target in prostate cancer. Nat Rev Urol. 2014;11(9):508–516. doi: 10.1038/nrurol.2014.196.
   PubMed Web of Science ®Google Scholar
• Deng R, Zhang HL, Huang JH, et al. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. Autophagy. 2021;17(10):3011–3029. doi: 10.1080/15548627.2020.1850609.
   PubMed Web of Science ®Google Scholar
• Hirota Y, Yamashita S. I, Kurihara Y, et al. Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 2015;11(2):332–343. doi: 10.1080/15548627.2015.1023047.
   PubMed Web of Science ®Google Scholar
• Ji J, Qin Y, Ren J, et al. Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN. Sci Rep. 2015;5(1):16262. doi: 10.1038/srep16262.
   PubMedGoogle Scholar
• Xu F, Hu Y, Gao J, et al. HIF-1α/Malat1/miR-141 axis activates autophagy to increase proliferation, migration, and invasion in triple-negative breast cancer. Curr Cancer Drug Targets. 2023;23(5):363–378. doi: 10.2174/1568009623666221228104833.
   PubMed Web of Science ®Google Scholar
• Liu C, Liu R, Zhang D, et al. MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nat Commun. 2017;8(1):14270. doi: 10.1038/ncomms14270.
   PubMedGoogle Scholar
• Xu S, Ge J, Zhang Z, et al. miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1. Oncol Rep. 2018;39(3):1454–1460. doi: 10.3892/or.2018.6209.
   PubMed Web of Science ®Google Scholar
• Richardsen E, Andersen S, Melbø-Jørgensen C, et al. MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer. Sci Rep. 2019;9(1):386. doi: 10.1038/s41598-018-36854-7.
   PubMedGoogle Scholar
• Li X, Liu B, Wang S, et al. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6. Chin J Physiol. 2023;66(1):43–51. doi: 10.4103/cjop.CJOP-D-22-00071.
   PubMed Web of Science ®Google Scholar
• Jou AFJ, Lu CH, Ou YC, et al. Diagnosing the miR-141 prostate cancer biomarker using nucleic acid-functionalized CdSe/ZnS QDs and telomerase. Chem Sci. 2015;6(1):659–665. doi: 10.1039/c4sc02104e.
   PubMed Web of Science ®Google Scholar
• Porzycki P, Ciszkowicz E, Semik M, et al. Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition. Int Urol Nephrol. 2018;50(9):1619–1626. doi: 10.1007/s11255-018-1938-2.
   PubMed Web of Science ®Google Scholar
• Ye Y, Yuan XH, Wang JJ, et al. The diagnostic value of miRNA-141 in prostate cancer: a systematic review and PRISMA-compliant meta-analysis. Medicine. 2020;99(22):e19993. doi: 10.1097/MD.0000000000019993.
   PubMed Web of Science ®Google Scholar
• Corcelle EA, Puustinen P, Jäättelä M. Apoptosis and autophagy: targeting autophagy signalling in cancer cells—‘trick or treats’? FEBS J. 2009;276(21):6084–6096. doi: 10.1111/j.1742-4658.2009.07332.x.
   PubMed Web of Science ®Google Scholar
• Hippert MM, O'Toole PS, Thorburn A. Autophagy in cancer: good, bad, or both? Cancer Res. 2006;66(19):9349–9351. doi: 10.1158/0008-5472.CAN-06-1597.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726–734. doi: 10.1038/nrc1692.
   PubMed Web of Science ®Google Scholar
• Kung HJ. Targeting tyrosine kinases and autophagy in prostate cancer. Horm Cancer. 2011;2(1):38–46. doi: 10.1007/s12672-010-0053-3.
   PubMedGoogle Scholar
• Bristol ML, Emery SM, Maycotte P, et al. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther. 2013;344(3):544–552. doi: 10.1124/jpet.112.199802.
   PubMed Web of Science ®Google Scholar
• Kumano M, Furukawa J, Shiota M, et al. Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer. Mol Cancer Ther. 2012;11(8):1661–1671. doi: 10.1158/1535-7163.MCT-12-0072.
   PubMed Web of Science ®Google Scholar
• Lamoureux F, Thomas C, Crafter C, et al. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel akt inhibitor AZD5363. Clin Cancer Res. 2013;19(4):833–844. doi: 10.1158/1078-0432.CCR-12-3114.
   PubMed Web of Science ®Google Scholar
• Yu L, Tumati V, Tseng SF, et al. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia. 2012;14(12):1203–1212. doi: 10.1593/neo.121310.
   PubMed Web of Science ®Google Scholar
• Todorova K, Metodiev MV, Metodieva G, et al. miR-204 is dysregulated in metastatic prostate cancer in vitro. Mol Carcinog. 2016;55(2):131–147. doi: 10.1002/mc.22263.
   PubMed Web of Science ®Google Scholar
• De Coster W, Rademakers R. NanoPack2: population-scale evaluation of long-read sequencing data. Bioinformatics. 2023;39(5):btad311. doi: 10.1093/bioinformatics/btad311.
   PubMed Web of Science ®Google Scholar
• Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–3100. doi: 10.1093/bioinformatics/bty191.
   PubMed Web of Science ®Google Scholar
• Iwashita H, Torii S, Nagahora N, et al. Live cell imaging of mitochondrial autophagy with a novel fluorescent small molecule. ACS Chem Biol. 2017;12(10):2546–2551. doi: 10.1021/acschembio.7b00647.
   PubMed Web of Science ®Google Scholar
• Iwashita H, Sakurai HT, Nagahora N, et al. Small fluorescent molecules for monitoring autophagic flux. FEBS Lett. 2018;592(4):559–567. doi: 10.1002/1873-3468.12979.
   PubMed Web of Science ®Google Scholar
• Wang H, Guo M, Wei H, et al. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92.
   PubMed Web of Science ®Google Scholar
• Shen S, Shao Y, Li C. Different types of cell death and their shift in shaping disease. Cell Death Discov. 2023;9(1):284. doi: 10.1038/s41420-023-01581-0.
   PubMed Web of Science ®Google Scholar
• Yogev O, Goldberg R, Anzi S, et al. Jun proteins are starvation-regulated inhibitors of autophagy. Cancer Res. 2010;70(6):2318–2327. doi: 10.1158/0008-5472.CAN-09-3408.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zhou M, Liu G, et al. Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis. Exp Ther Med. 2017;13(5):2348–2354. doi: 10.3892/etm.2017.4287.
   PubMed Web of Science ®Google Scholar
• Sun T, Li D, Wang L, et al. c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J Transl Med. 2011;9(1):161. doi: 10.1186/1479-5876-9-161.
   PubMedGoogle Scholar
• Das S, Shukla N, Singh SS, et al. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis. 2021;26(9–10):512–533. doi: 10.1007/s10495-021-01687-9.
   PubMed Web of Science ®Google Scholar
• Williams T, Forsberg LJ, Viollet B, et al. Basal autophagy induction without AMP-activated protein kinase under low glucose conditions. Autophagy. 2009;5(8):1155–1165. doi: 10.4161/auto.5.8.10090.
   PubMed Web of Science ®Google Scholar
• Boya P, González-Polo RA, Casares N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25(3):1025–1040. doi: 10.1128/MCB.25.3.1025-1040.2005.
   PubMed Web of Science ®Google Scholar
• Rubinstein AD, Eisenstein M, Ber Y, et al. The autophagy protein Atg12 associates with antiapoptotic bcl-2 family members to promote mitochondrial apoptosis. Mol Cell. 2011;44(5):698–709. doi: 10.1016/j.molcel.2011.10.014.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Hirata N, Tanaka T, et al. Autophagy as a modulator of cell death machinery. Cell Death Dis. 2020;11(7):517. doi: 10.1038/s41419-020-2724-5.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Hirata N, Suizu F. The links between AKT and two intracellular proteolytic Cascades: ubiquitination and autophagy. Biochim Biophys Acta. 2014;1846(2):342–352. doi: 10.1016/j.bbcan.2014.07.013.
   PubMed Web of Science ®Google Scholar
• Matsuda-Lennikov M, Suizu F, Hirata N, et al. Lysosomal interaction of Akt with Phafin2: a critical step in the induction of autophagy. PLoS One. 2014;9(1):e79795. doi: 10.1371/journal.pone.0079795.
   PubMed Web of Science ®Google Scholar
• Xie CM, Chan WY, Yu S, et al. Bufalin induces autophagy-mediated cell death in human Colon cancer cells through reactive oxygen species generation and JNK activation. Free Radic Biol Med. 2011;51(7):1365–1375. doi: 10.1016/j.freeradbiomed.2011.06.016.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17(1):1–382. doi: 10.1080/15548627.2020.1797280.
   PubMed Web of Science ®Google Scholar
• Wu W, Tian W, Hu Z, et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014;15(5):566–575. doi: 10.1002/embr.201438501.
   PubMed Web of Science ®Google Scholar
• Poole LP, Bock-Hughes A, Berardi DE, et al. ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3. Sci Rep. 2021;11(1):20526. doi: 10.1038/s41598-021-00170-4.
   PubMed Web of Science ®Google Scholar
• He YL, Li J, Gong SH, et al. BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia. Cell Death Dis. 2022;13(11):966. doi: 10.1038/s41419-022-05418-z.
   PubMed Web of Science ®Google Scholar
• Jung S, Jeong H, Yu SW. Autophagy as a decisive process for cell death. Exp Mol Med. 2020;52(6):921–930. doi: 10.1038/s12276-020-0455-4.
   PubMed Web of Science ®Google Scholar
• El Hout M, Cosialls E, Mehrpour M, et al. Crosstalk between autophagy and metabolic regulation of cancer stem cells. Mol Cancer. 2020;19(1):27. doi: 10.1186/s12943-019-1126-8.
   PubMed Web of Science ®Google Scholar
• Guo JY, Karsli-Uzunbas G, Mathew R, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 2013;27(13):1447–1461. doi: 10.1101/gad.219642.113.
   PubMed Web of Science ®Google Scholar
• Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell. 2013;155(6):1216–1219. doi: 10.1016/j.cell.2013.11.019.
   PubMed Web of Science ®Google Scholar
• Qi W, Cooke LS, Stejskal A, et al. MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/akt pathway and tumor growth in prostate cancer. BMC Cancer. 2009;9(1):142. doi: 10.1186/1471-2407-9-142.
   PubMedGoogle Scholar
• Chetram MA, Odero-Marah V, Hinton CV. Loss of PTEN permits CXCR4-Mediated tumorigenesis through ERK1/2 in prostate cancer cells. Mol Cancer Res. 2011;9(1):90–102. doi: 10.1158/1541-7786.MCR-10-0235.
   PubMed Web of Science ®Google Scholar
• Jamaspishvili T, Patel PG, Niu Y, et al. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). J Natl Cancer Inst. 2020;112(11):1098–1104. doi: 10.1093/jnci/djaa032.
   PubMedGoogle Scholar
• Gioeli D, Mandell JW, Petroni GR, et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 1999;59(2):279–284.
   PubMed Web of Science ®Google Scholar